191 related articles for article (PubMed ID: 36280432)
1. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports.
Cho S; Jang S; Ryu SS; Park S
Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
3. Necessity and choice of therapy for Henoch-Schönlein purpura nephritis.
Kurokawa M; Maehara K; Kaku Y; Honjo S
Pediatr Int; 2022 Jan; 64(1):e15282. PubMed ID: 36134650
[TBL] [Abstract][Full Text] [Related]
4. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
Jelusic M; Sestan M; Cimaz R; Ozen S
Pediatr Rheumatol Online J; 2019 Feb; 17(1):10. PubMed ID: 30819179
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
6. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
7. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children.
Fu H; Mao J; Xu Y; Gu W; Zhu X; Liu A
Clinics (Sao Paulo); 2016 Sep; 71(9):550-4. PubMed ID: 27652838
[TBL] [Abstract][Full Text] [Related]
10. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
[TBL] [Abstract][Full Text] [Related]
11. Analysis of children with Henoch-Schonlein purpura secondary to infection.
Liu C; Luo L; Fu M; Li Z; Liu J
Clin Rheumatol; 2022 Mar; 41(3):803-810. PubMed ID: 34993728
[TBL] [Abstract][Full Text] [Related]
12. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
Yu M; Song X; Guo J; Feng Q; Tian J
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38668796
[TBL] [Abstract][Full Text] [Related]
13. Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schönlein purpura nephritis of moderate severity.
Nagai S; Horinouchi T; Ninchoji T; Kondo A; Aoto Y; Ishiko S; Sakakibara N; Nagano C; Yamamura T; Kaito H; Tanaka R; Shima Y; Fujimura J; Kamiyoshi N; Ishimori S; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Pediatr Nephrol; 2022 Aug; 37(8):1845-1853. PubMed ID: 35015121
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between clinical manifestations and renal pathology in children with Henoch-Schonlein purpura nephritis].
Zhang GZ; Wu XC; Yi H; Peng XJ; Dang XQ; He XJ; Yi ZW
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):129-32. PubMed ID: 17448308
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
16. Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Wang J; Ying Q; Zhong S; Chen Y; Di Y; Dai X; Zheng J; Shen M
Pediatr Neonatol; 2018 Jun; 59(3):238-243. PubMed ID: 28919104
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.
Lu Z; Song J; Mao J; Xia Y; Wang C
Med Sci Monit; 2017 May; 23():2333-2339. PubMed ID: 28515415
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide therapy for IgA vasculitis with nephritis in children.
Hou L; Zhang Z; Du Y
BMC Pediatr; 2021 Sep; 21(1):391. PubMed ID: 34496826
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexamethasone and gamma globulin combined with prednisone on the therapeutic effect and immune function of Henoch-Schonlein purpura nephritis in children.
Chen L; Wang X; Yin L; Ma K; Liu X
J Clin Lab Anal; 2021 Jan; 35(1):e23580. PubMed ID: 33174652
[TBL] [Abstract][Full Text] [Related]
20. Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials.
Xue X; Liu XH; Lu CL; Jin XY; Liu Q; Wang XQ; Liu JP
BMC Complement Med Ther; 2021 Nov; 21(1):278. PubMed ID: 34743723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
